Synthesis and antimicrobial activity of 2-fluorophenyl-4,6-disubstituted [1,3,5]triazines

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 3, 2010, Pages 945-949

  Saleh, Mona ^a   Abbott, Shaun ^a   Perron, Valérie ^a   Lauzon, Caroline ^a   Penney, Christopher ^a   Zacharie, Boulos ^a  

^a ProMetic Life Sciences Inc   (Canada)

Author keywords

Antimicrobial activity; Drug resistance; Fluorophenyl triazines; Rigid alkyl amines

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; STREPTOMYCIN SULFATE; TRIAZINE DERIVATIVE; UNCLASSIFIED DRUG; [1,3,5]TRIAZINE;

ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; CANDIDA ALBICANS; CONTROLLED STUDY; DISK DIFFUSION; DRUG SCREENING; DRUG SYNTHESIS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; NONHUMAN; PROPIONIBACTERIUM ACNES; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS COHNII; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS WARNERI; STREPTOCOCCUS PNEUMONIAE; STRUCTURE ACTIVITY RELATION; COMPARATIVE STUDY; DRUG EFFECTS; GRAM POSITIVE BACTERIUM; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY; PROCEDURES; SYNTHESIS;

FUNGI; POSIBACTERIA;

ANTI-INFECTIVE AGENTS; CANDIDA ALBICANS; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; TRIAZINES;

EID: 74349100375     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.12.063     Document Type: Article

References (23)

1. Chu D.T.W., Plattner J.J., and Katz L. J. Med. Chem 39 (1996) 3853
2. Beovic B. Int. J. Food Microbiol. 112 (2006) 280
3. Finch R., and Hunter P.A. J. Antimicrob. Chemother. 58 (2006) i3
4. Suree N., Jung M.E., and Clubb R.T. Mini-Rev. Med. Chem. 7 (2007) 991
5. Clark A.M. Pharm. Res. 13 (1996) 1133
6. Cowan M.M. Clin. Microbiol. Rev. 12 (1999) 564
7. Rex J.H., Walsh T.J., Sobel J.D., Filler S.G., Pappas P.G., Dismukes W.E., and Edwards J.E. Clin. Infect. Dis. 30 (2000) 662
8. Sanglard D., and Odds F.C. Lancet Infect. Dis. 2 (2002) 73
9. Buzzini P., Arapitsas P., Goretti M., Branda E., Turchetti B., Pinelli P., Ieri F., and Romani A. Mini-Rev. Med. Chem. 8 (2008) 1179
10. Blotny G. Tetrahedron 62 (2006) 9507 and references cited therein
11. Baliani A., Bueno G.J., Stewart M.L., Yardlev V., Brun R., Barrett M.P., and Gilbert I.H. J. Med. Chem. 48 (2005) 5570
12. Menicagli R., Samaritani S., Signore G., Vaglini F., and Via L.D. J. Med. Chem. 47 (2004) 4649
13. Melato S., Prosperi D., Coghi P., Basilico B., and Monti D. ChemMedChem 3 (2008) 873 and references cited therein
14. Xiong Y.-Z., Chen F.-E., Balzarini J., De Clercq E., and Pannecouque C. Eur. J. Med. Chem. 43 (2008) 1230 and references cited therein
15. Zhou C., Min J., Liu Z., Young Z., Deshazer H., Gao T., Chang Y.-T., and Kallenbach R. Bioorg. Med. Chem. Lett. 18 (2008) 1308
16. Srinivas K., Srinivas U., Bhanuprakash K., Harakishore K., Murthy U.S.N., and Jayathirtha Rao V. Eur. J. Med. Chem. 41 (2006) 1240
17. Poyser, J. P.; Telford, B.; Timms, D.; Block, M. H.; Hales Neil, J. WO 1999/01442.
18. Unpublished results.
19. R = 5.19 min; (254 nm) 100%.
20. Bork J.T., Lee J.W., and Chang Y.-T. Tetrahedron Lett. 44 (2003) 6141
21. Reich M.F., Fabio P.F., Lee V.J., Kuck N.A., and Testa R.T. J. Med. Chem. 32 (1989) 2474
22. The activity of amphotericin B against C. albicans is not directly associated with extracellular calcium concentration:. Rogers P.D., Kramer R.E., Crews J.K., and Lewis R.E. J. Antimicrob. Chemother. 51 (2003) 305
23. In vitro activities of amphotericin-B in combination with rifampin against Aspergillus species:. Zarrin M., and Najafi M.R. Pak. J. Med. Sci. 23 (2007) 323